A new class of biologic
drugs came onto the market in Canada last year, and while more effective for treating high - cholesterol, they are also more expensive.
Controversial deals that delay generic versions of
drugs coming onto the market can lead to consumers paying significantly more for some treatments, according to new research by an academic from the University of East Anglia.
Almost weekly, a new synthetic psychoactive
drug comes onto the market somewhere in Europe that can be ordered legally and easily, for example as an incense blend, via the Internet.
Not exact matches
Dr Bokhari said: «The
drug companies argue that they have a right to protect their intellectual property and that these agreements benefit consumers by enabling generic versions to
come onto the
market sooner than they would normally have, for example if licensed entry has been allowed at a later date but before the patent expires.